₹ 574.95
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
BDH Industries Limited specializes in the development and manufacture of therapeutic pharmaceutical products. Its extensive portfolio of medicines includes fentanyl citrate injection, acetaminophen oral solution, both tablet and injectable forms of paracetamol, benzyl benzoate application, praziquantel, mebendazole, thioridazine available as an oral solution and in tablet form, and haloperidol injection. The company was established in 1935 and is headquartered in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITD.
Data is available to registered users only